These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 469372)
1. Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3. Massry SG; Tuma S; Dua S; Goldstein DA J Lab Clin Med; 1979 Jul; 94(1):152-7. PubMed ID: 469372 [TBL] [Abstract][Full Text] [Related]
2. Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3. Massry SG; Stein R; Garty J; Arieff AI; Coburn JW; Norman AW; Friedler RM Kidney Int; 1976 Jun; 9(6):467-74. PubMed ID: 940279 [TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
4. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination. Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862 [TBL] [Abstract][Full Text] [Related]
5. Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity. Goldstein DA; Chui LA; Massry SG J Clin Invest; 1978 Jul; 62(1):88-93. PubMed ID: 659642 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D metabolites do not alter parathyroid hormone secretion acutely. Magliola L; Anast CS; Forte LR Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783 [TBL] [Abstract][Full Text] [Related]
7. Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites. Somerville PJ; Kaye M Kidney Int; 1978 Sep; 14(3):245-54. PubMed ID: 723151 [TBL] [Abstract][Full Text] [Related]
8. Effect of 1,25(OH)2D3 and 24,25(OH)2D3 on experimental rickets. Kraft D; Offermann G; Steldinger R; Gawlik D Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):571-80. PubMed ID: 523788 [TBL] [Abstract][Full Text] [Related]
9. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content. Takahashi F; Finch JL; Denda M; Dusso AS; Brown AJ; Slatopolsky E Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408 [TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man. Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193 [TBL] [Abstract][Full Text] [Related]
11. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728 [TBL] [Abstract][Full Text] [Related]
12. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone. Marcus R; Orner FB; Brickman AS Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269 [TBL] [Abstract][Full Text] [Related]
13. The role of phosphorus in the genesis of azotemic osteodystrophy. Somerville PJ; Kaye M Prog Biochem Pharmacol; 1980; 17():228-35. PubMed ID: 6894195 [TBL] [Abstract][Full Text] [Related]
14. Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone. Galceran T; Martin KJ; Morrissey JJ; Slatopolsky E Kidney Int; 1987 Dec; 32(6):801-7. PubMed ID: 3430963 [TBL] [Abstract][Full Text] [Related]
15. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism. Lambert PW; Hollis BW; Bell NH; Epstein S J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719 [TBL] [Abstract][Full Text] [Related]
16. Selective deficiency of 1,25-dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone. Metz SA; Baylink DJ; Hughes MR; Haussler MR; Robertson RP N Engl J Med; 1977 Nov; 297(20):1084-90. PubMed ID: 198661 [TBL] [Abstract][Full Text] [Related]
17. Hypocalcemic effect of 24R, 25-dihydroxyvitamin D3 in rats. Maeda Y; Yamato H; Katoh T; Orimo H In Vivo; 1987; 1(6):347-50. PubMed ID: 2979802 [TBL] [Abstract][Full Text] [Related]
18. Regulation of calcitonin gene transcription by vitamin D metabolites in vivo in the rat. Naveh-Many T; Silver J J Clin Invest; 1988 Jan; 81(1):270-3. PubMed ID: 2891728 [TBL] [Abstract][Full Text] [Related]
19. Effect of 24,25(OH)2D3 on PTH levels and bone histology in dogs with chronic uremia. Olgaard K; Finco D; Schwartz J; Arbelaez M; Teitelbaum S; Avioli L; Klahr S; Slatopolsky E Kidney Int; 1984 Dec; 26(6):791-7. PubMed ID: 6335904 [TBL] [Abstract][Full Text] [Related]
20. 1,25 dihydroxycholecalciferol treatment of uraemic rats after high magnesium feeding. Binswanger U; Schiffl H; Huggler M; Becker C Proc Eur Dial Transplant Assoc; 1980; 17():563-8. PubMed ID: 6894642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]